Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875378 · ClinicalTrials.gov registry record · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
A Phase 2 study of Anorexia Nervosa, sponsored by Pouneh K. Fazeli, MD.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT03875378: Recruiting Phase 2 study of Anorexia Nervosa, sponsored by Pouneh K. Fazeli, MD.
NCT03875378 is a Phase 2 study of Anorexia Nervosa that is actively recruiting participants, run by Pouneh K. Fazeli, MD. The registered enrollment target is 66 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03875378, a Phase 2 study of Anorexia Nervosa, is actively recruiting participants, sponsored by Pouneh K. Fazeli, MD.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.
Primary Outcome
Change in lumbar spine bone mineral density at 18 months
Conditions Studied
Interventions
- DRUG Placebos
- DRUG Transdermal estrogen
Study Locations (1)
Pennsylvania
- University of Pittsburgh School of Medicine - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2020-08-28 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 2 |
What NCT03875378 shows while recruiting
NCT03875378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Placebos is the first listed.
NCT03875378 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03875378 about?
NCT03875378 is a clinical study titled "Transdermal Estrogen in Women With Anorexia Nervosa". Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.
What is the current status of trial NCT03875378?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2020-08-28. Estimated completion is 2028-12-31.
What conditions does trial NCT03875378 study?
This clinical trial studies the following conditions: Anorexia Nervosa.
What interventions are being tested in trial NCT03875378?
The interventions under investigation include: Placebos (DRUG), Transdermal estrogen (DRUG).
Who is sponsoring clinical trial NCT03875378?
This trial is sponsored by Pouneh K. Fazeli, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03875378 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03875378's enrollment target sits among peer trials
66 20th of 43 higher than 24 of 43 other Anorexia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Psilocybin for Anorexia in Young Adults
RECRUITING · Phase 2
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT04029623 · 66 participants · NA
Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI